Results 21 to 30 of about 263 (55)

A Novel Case of CMV Resistance to Valganciclovir and Maribavir in a Renal Transplant Patient. [PDF]

Transpl Int
Pearce H, Montgomery EK, Sheerin N, Ellam H.   +3 more
europepmc   +1 more source

Combinatorial Drug Treatments Reveal Promising Anticytomegaloviral Profiles for Clinically Relevant Pharmaceutical Kinase Inhibitors (PKIs). [PDF]

Int J Mol Sci, 2021
Wild M, Kicuntod J, Seyler L, Wangen C, Bertzbach LD, Conradie AM, Kaufer BB, Wagner S, Michel D, Eickhoff J, Tsogoeva SB, Bäuerle T, Hahn F, Marschall M.   +13 more
europepmc   +1 more source

[Maribavir effectively treated three patients with human herpesvirus-6B infection after allogeneic hematopoietic stem cell transplantation]. [PDF]

Zhonghua Xue Ye Xue Za Zhi
Jin CW, Li S, Wang LX, Huang JY, Hu XX, Zhang ZL.   +5 more
europepmc   +1 more source

Real-World Comparison of Maribavir to Foscarnet for the Treatment of Cytomegalovirus in Solid Organ and Hematopoietic Stem Cell Transplant Recipients. [PDF]

Viruses
Ogawa L, Morinishi C, Multani A, Gaynor P, Beaird OE, Pham C, Schaenman JM.   +6 more
europepmc   +1 more source

Use of Maribavir for Multidrug Resistant Cytomegaloviremia in a Pediatric Oncology Patient. [PDF]

J Pediatr Hematol Oncol
Fisher JE, Mulieri K, Finch E, Ericson JE.   +3 more
europepmc   +1 more source

Evaluating Real-World Experience With Maribavir for Treatment of Refractory/Resistant Cytomegalovirus in Renal Transplant Recipients. [PDF]

Clin Transplant
Beechar VB, Phadke VK, Pouch SM, Mehta AK, Karadkhele G, Larsen CP, Woodworth MH.   +6 more
europepmc   +1 more source

Population Pharmacokinetics and Exposure-Response Relationships of Maribavir in Transplant Recipients With First Episode or Refractory Cytomegalovirus. [PDF]

CPT Pharmacometrics Syst Pharmacol
Sun K, Jomphe C, Gosselin NH, Pheng L, Durairaj C, Hang Y, Bhattacharya I.   +6 more
europepmc   +1 more source

The Troll Is Weakened but Not yet Defeated: An Update on Cytomegalovirus Management in Transplantation From the International CMV Symposium 2025. [PDF]

Transpl Infect Dis
Kotton CN, Sester M, Torre-Cisneros J, International CMV Symposium Faculty.   +3 more
europepmc   +1 more source

Neuroprotective Effects of Hesperidin and CK2 Inhibitor DRB on Aβ_1-42-Induced Neurotoxicity in Differentiated SH-SY5Y Cells. [PDF]

Mol Neurobiol
Eciroglu-Sarban H, Altin-Celik P, Kelicen-Ugur P, Donmez-Altuntas H.   +3 more
europepmc   +1 more source

Comparative Emergence of Maribavir and Ganciclovir Resistance in a Randomized Phase 3 Clinical Trial for Treatment of Cytomegalovirus Infection. [PDF]

J Infect Dis
Chou S, Winston DJ, Avery RK, Cordonnier C, Duarte RF, Haider S, Maertens J, Peggs KS, Solano C, Young JH, Gu J, Pocock G, Papanicolaou GA.   +12 more
europepmc   +1 more source